 Bradford Smith
Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventilator-Induced Lung Injury | 17 | 2024 | 59 | 6.660 |
Why?
| | Positive-Pressure Respiration | 13 | 2024 | 80 | 2.580 |
Why?
| | Lung | 28 | 2025 | 4063 | 2.240 |
Why?
| | Respiration, Artificial | 16 | 2024 | 642 | 2.050 |
Why?
| | Respiratory Mechanics | 9 | 2024 | 67 | 1.690 |
Why?
| | Acute Lung Injury | 6 | 2024 | 287 | 1.680 |
Why?
| | Lung Injury | 5 | 2024 | 218 | 1.280 |
Why?
| | Pulmonary Alveoli | 10 | 2025 | 405 | 1.210 |
Why?
| | Pulmonary Surfactants | 5 | 2020 | 106 | 1.060 |
Why?
| | Models, Biological | 7 | 2020 | 1773 | 0.970 |
Why?
| | Tidal Volume | 8 | 2024 | 86 | 0.950 |
Why?
| | Ventilators, Mechanical | 3 | 2024 | 58 | 0.760 |
Why?
| | Equipment Design | 3 | 2020 | 521 | 0.700 |
Why?
| | Computer Simulation | 11 | 2022 | 973 | 0.660 |
Why?
| | Laryngoscopes | 1 | 2020 | 38 | 0.660 |
Why?
| | Continuous Positive Airway Pressure | 3 | 2016 | 83 | 0.650 |
Why?
| | Bleomycin | 3 | 2024 | 247 | 0.630 |
Why?
| | Laryngoscopy | 1 | 2020 | 109 | 0.620 |
Why?
| | Animals | 34 | 2025 | 36850 | 0.570 |
Why?
| | Mice | 15 | 2025 | 17759 | 0.470 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 368 | 0.470 |
Why?
| | Coronavirus Infections | 1 | 2020 | 358 | 0.470 |
Why?
| | Pulmonary Atelectasis | 3 | 2024 | 15 | 0.470 |
Why?
| | Algorithms | 4 | 2020 | 1690 | 0.440 |
Why?
| | Pressure | 4 | 2024 | 221 | 0.440 |
Why?
| | Mice, Inbred BALB C | 5 | 2019 | 1269 | 0.440 |
Why?
| | Blood-Air Barrier | 2 | 2025 | 11 | 0.410 |
Why?
| | Disease Models, Animal | 10 | 2025 | 4282 | 0.400 |
Why?
| | Pulmonary Surfactant-Associated Protein B | 2 | 2025 | 6 | 0.400 |
Why?
| | Alveolar Epithelial Cells | 4 | 2022 | 114 | 0.360 |
Why?
| | Complex Mixtures | 1 | 2009 | 11 | 0.330 |
Why?
| | Cigarette Smoking | 2 | 2022 | 101 | 0.320 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2025 | 382 | 0.310 |
Why?
| | Respiratory Function Tests | 4 | 2018 | 595 | 0.310 |
Why?
| | Microfluidics | 1 | 2009 | 54 | 0.310 |
Why?
| | Vitamin D | 2 | 2025 | 397 | 0.310 |
Why?
| | Rats | 9 | 2025 | 5639 | 0.310 |
Why?
| | Models, Chemical | 1 | 2009 | 263 | 0.290 |
Why?
| | Rats, Sprague-Dawley | 7 | 2025 | 2486 | 0.250 |
Why?
| | Inhalation | 1 | 2025 | 29 | 0.240 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2025 | 71 | 0.230 |
Why?
| | Mice, Inbred C57BL | 6 | 2025 | 5750 | 0.220 |
Why?
| | Tissue Fixation | 1 | 2024 | 36 | 0.220 |
Why?
| | Respiration | 3 | 2019 | 199 | 0.210 |
Why?
| | Leukocytes | 2 | 2022 | 311 | 0.210 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2023 | 31 | 0.210 |
Why?
| | Golgi Apparatus | 1 | 2024 | 100 | 0.210 |
Why?
| | Neutrophil Infiltration | 1 | 2023 | 107 | 0.200 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2024 | 165 | 0.200 |
Why?
| | Lung Compliance | 2 | 2020 | 49 | 0.200 |
Why?
| | Humans | 23 | 2025 | 136803 | 0.200 |
Why?
| | Acetaminophen | 1 | 2025 | 266 | 0.190 |
Why?
| | Glycocalyx | 1 | 2022 | 27 | 0.190 |
Why?
| | Glycosaminoglycans | 1 | 2022 | 83 | 0.180 |
Why?
| | Pulmonary Medicine | 1 | 2022 | 85 | 0.180 |
Why?
| | Endoplasmic Reticulum | 1 | 2024 | 264 | 0.180 |
Why?
| | Biomechanical Phenomena | 4 | 2022 | 806 | 0.180 |
Why?
| | Lipopolysaccharides | 1 | 2024 | 886 | 0.180 |
Why?
| | Nonlinear Dynamics | 2 | 2018 | 88 | 0.170 |
Why?
| | Respiratory Rate | 1 | 2020 | 20 | 0.170 |
Why?
| | Proof of Concept Study | 1 | 2020 | 78 | 0.170 |
Why?
| | Epithelium | 1 | 2021 | 311 | 0.170 |
Why?
| | Needles | 1 | 2020 | 59 | 0.160 |
Why?
| | Models, Anatomic | 1 | 2020 | 92 | 0.160 |
Why?
| | Healthy Volunteers | 1 | 2020 | 199 | 0.160 |
Why?
| | Pulmonary Ventilation | 1 | 2020 | 79 | 0.160 |
Why?
| | Pulmonary Surfactant-Associated Proteins | 1 | 2019 | 10 | 0.160 |
Why?
| | Printing, Three-Dimensional | 1 | 2020 | 94 | 0.160 |
Why?
| | Pulmonary Emphysema | 1 | 2022 | 288 | 0.160 |
Why?
| | Hyperoxia | 1 | 2020 | 90 | 0.160 |
Why?
| | Th17 Cells | 1 | 2020 | 109 | 0.160 |
Why?
| | Respiratory Tract Infections | 1 | 2023 | 394 | 0.150 |
Why?
| | Male | 14 | 2025 | 67330 | 0.150 |
Why?
| | Vitamin D Deficiency | 1 | 2020 | 186 | 0.140 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2018 | 127 | 0.140 |
Why?
| | Sensitivity and Specificity | 2 | 2015 | 1936 | 0.140 |
Why?
| | Reproducibility of Results | 3 | 2022 | 3265 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 266 | 0.140 |
Why?
| | Macrophages, Alveolar | 1 | 2020 | 391 | 0.130 |
Why?
| | Down Syndrome | 1 | 2023 | 490 | 0.130 |
Why?
| | Animals, Newborn | 3 | 2025 | 844 | 0.130 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2019 | 655 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 556 | 0.130 |
Why?
| | Elasticity | 2 | 2015 | 197 | 0.120 |
Why?
| | Pulmonary Fibrosis | 1 | 2019 | 399 | 0.120 |
Why?
| | Tensile Strength | 1 | 2015 | 97 | 0.110 |
Why?
| | Neutrophils | 1 | 2020 | 1236 | 0.110 |
Why?
| | Elastic Modulus | 1 | 2015 | 123 | 0.110 |
Why?
| | Therapy, Computer-Assisted | 1 | 2015 | 62 | 0.110 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 1036 | 0.110 |
Why?
| | Lung Diseases | 1 | 2020 | 768 | 0.110 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2021 | 654 | 0.110 |
Why?
| | Hypertension, Pulmonary | 1 | 2025 | 1905 | 0.100 |
Why?
| | X-Ray Microtomography | 2 | 2024 | 94 | 0.100 |
Why?
| | Surface Tension | 2 | 2025 | 8 | 0.100 |
Why?
| | Biomedical Engineering | 1 | 2012 | 27 | 0.100 |
Why?
| | Doxycycline | 2 | 2025 | 62 | 0.100 |
Why?
| | Pandemics | 1 | 2020 | 1616 | 0.090 |
Why?
| | Hydrodynamics | 1 | 2011 | 42 | 0.090 |
Why?
| | Prognosis | 2 | 2022 | 4013 | 0.090 |
Why?
| | Recovery of Function | 1 | 2015 | 652 | 0.090 |
Why?
| | Random Allocation | 3 | 2016 | 353 | 0.080 |
Why?
| | Computer-Aided Design | 1 | 2009 | 42 | 0.080 |
Why?
| | Equipment Failure Analysis | 1 | 2009 | 131 | 0.080 |
Why?
| | Mice, Transgenic | 2 | 2025 | 2163 | 0.070 |
Why?
| | Rats, Inbred F344 | 2 | 2020 | 264 | 0.070 |
Why?
| | Asthma | 1 | 2020 | 2282 | 0.070 |
Why?
| | Pregnancy | 3 | 2025 | 6729 | 0.060 |
Why?
| | Cytochrome P-450 CYP2E1 | 1 | 2025 | 31 | 0.060 |
Why?
| | Mice, Knockout | 2 | 2025 | 3009 | 0.060 |
Why?
| | Disease Progression | 1 | 2013 | 2751 | 0.060 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2025 | 93 | 0.060 |
Why?
| | Methacholine Chloride | 1 | 2024 | 52 | 0.060 |
Why?
| | Linear Models | 2 | 2018 | 846 | 0.050 |
Why?
| | Adolescent | 2 | 2020 | 21385 | 0.050 |
Why?
| | Cell Size | 1 | 2024 | 91 | 0.050 |
Why?
| | Female | 8 | 2025 | 72816 | 0.050 |
Why?
| | STAT3 Transcription Factor | 1 | 2025 | 206 | 0.050 |
Why?
| | Endotoxins | 1 | 2024 | 220 | 0.050 |
Why?
| | Biology | 1 | 2023 | 88 | 0.050 |
Why?
| | Biophysics | 1 | 2022 | 69 | 0.050 |
Why?
| | Tyrphostins | 1 | 2021 | 18 | 0.050 |
Why?
| | Amphiregulin | 1 | 2021 | 25 | 0.050 |
Why?
| | Biophysical Phenomena | 1 | 2021 | 63 | 0.050 |
Why?
| | Keratin-5 | 1 | 2021 | 50 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2025 | 778 | 0.040 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 278 | 0.040 |
Why?
| | Leukosialin | 1 | 2020 | 14 | 0.040 |
Why?
| | Mannose-Binding Lectins | 1 | 2020 | 11 | 0.040 |
Why?
| | Optical Devices | 1 | 2020 | 13 | 0.040 |
Why?
| | Lectins, C-Type | 1 | 2020 | 67 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2015 | 10748 | 0.040 |
Why?
| | Respiratory Hypersensitivity | 1 | 2020 | 69 | 0.040 |
Why?
| | Signal Transduction | 2 | 2025 | 5077 | 0.040 |
Why?
| | Quinazolines | 1 | 2021 | 250 | 0.040 |
Why?
| | Electric Impedance | 1 | 2020 | 107 | 0.040 |
Why?
| | Acinar Cells | 1 | 2019 | 13 | 0.040 |
Why?
| | Cell Count | 1 | 2020 | 323 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2025 | 778 | 0.040 |
Why?
| | Mucin-5B | 1 | 2021 | 224 | 0.040 |
Why?
| | Mitochondria | 1 | 2025 | 946 | 0.040 |
Why?
| | Air | 1 | 2018 | 37 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 429 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 570 | 0.040 |
Why?
| | Receptors, Cell Surface | 1 | 2020 | 382 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2021 | 613 | 0.040 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2018 | 200 | 0.040 |
Why?
| | Eosinophils | 1 | 2020 | 332 | 0.040 |
Why?
| | Synchrotrons | 1 | 2017 | 13 | 0.030 |
Why?
| | Allergens | 1 | 2020 | 408 | 0.030 |
Why?
| | Tissue Donors | 1 | 2020 | 417 | 0.030 |
Why?
| | Gastroesophageal Reflux | 1 | 2019 | 234 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2022 | 2022 | 0.030 |
Why?
| | Forced Expiratory Flow Rates | 1 | 2016 | 14 | 0.030 |
Why?
| | Fibroblasts | 1 | 2021 | 993 | 0.030 |
Why?
| | Risk Factors | 2 | 2021 | 10332 | 0.030 |
Why?
| | Sex Factors | 1 | 2022 | 2064 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1733 | 0.030 |
Why?
| | Thoracotomy | 1 | 2016 | 75 | 0.030 |
Why?
| | Rabbits | 1 | 2017 | 792 | 0.030 |
Why?
| | Lung Diseases, Interstitial | 1 | 2022 | 636 | 0.030 |
Why?
| | Airway Resistance | 1 | 2015 | 36 | 0.030 |
Why?
| | Peak Expiratory Flow Rate | 1 | 2014 | 37 | 0.030 |
Why?
| | Environmental Exposure | 1 | 2019 | 572 | 0.030 |
Why?
| | Pulmonary Gas Exchange | 1 | 2014 | 121 | 0.030 |
Why?
| | Microscopy | 1 | 2016 | 145 | 0.030 |
Why?
| | Models, Animal | 1 | 2016 | 384 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2015 | 195 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2021 | 2831 | 0.030 |
Why?
| | Transcription Factors | 1 | 2021 | 1718 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2412 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3540 | 0.020 |
Why?
| | Fibrosis | 1 | 2015 | 552 | 0.020 |
Why?
| | Age Factors | 1 | 2019 | 3286 | 0.020 |
Why?
| | Smoking | 1 | 2019 | 1620 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2014 | 441 | 0.020 |
Why?
| | Surface Properties | 1 | 2011 | 412 | 0.020 |
Why?
| | Cell Death | 1 | 2011 | 372 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2835 | 0.020 |
Why?
| | Computational Biology | 1 | 2011 | 643 | 0.020 |
Why?
| | Cell Line | 1 | 2011 | 2838 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3406 | 0.010 |
Why?
| | Aged | 1 | 2020 | 23808 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 33239 | 0.010 |
Why?
| | Adult | 1 | 2020 | 37643 | 0.010 |
Why?
|
|
Smith's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|